Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Scientific Reports|November 2, 2017
Transition state-based ST6Gal I inhibitors: Mimicking the phosphodiester linkage with a triazole or carbamate through an enthalpy-entropy compensationAndrew P Montgomery, Danielle Skropeta, Haibo YuEuropean Journal of Medicinal Chemistry|April 8, 2025
The adamantane scaffold: Beyond a lipophilic moietyChianna Dane, Andrew P Montgomery, Michael KassiouBiochimie|May 23, 2024
Structure-based drug design for TSPO: Challenges and opportunitiesMia Giladi, Andrew P Montgomery, Michael Kassiou, et al.RSC Medicinal Chemistry|November 15, 2021
Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitorsChristopher Dobie, Andrew P Montgomery, Rémi Szabo, et al.Advances in Protein Chemistry and Structural Biology|July 8, 2017
Computational Glycobiology: Mechanistic Studies of Carbohydrate-Active Enzymes and Implication for Inhibitor DesignAndrew P Montgomery, Kela Xiao, Xingyong Wang, et al.Expert Opinion on Drug Discovery|April 28, 2023
An update on late-stage functionalization in today's drug discoveryAndrew P Montgomery, Jack M Joyce, Jonathan J Danon, et al.Journal of Molecular Recognition : JMR|November 10, 2017
Computer-aided design of human sialyltransferase inhibitors of hST8Sia IIIChristopher Dobie, Andrew P Montgomery, Rémi Szabo, et al.Chemical Reviews|June 7, 2023
Late-stage Functionalization for Improving Drug-like Molecular PropertiesNathan J Castellino, Andrew P Montgomery, Jonathan J Danon, et al.Bioorganic & Medicinal Chemistry Letters|May 31, 2022
Strategies for targeting the P2Y12 receptor in the central nervous systemBen B Ma, Andrew P Montgomery, Biling Chen, et al.European Journal of Medicinal Chemistry|December 15, 2020
The discovery of a potent and selective pyrazolo-[2,3-e]-[1,2,4]-triazine cannabinoid type 2 receptor agonistMichael Moir, Samuel Lane, Andrew P Montgomery, et al.Pageof 3